☆ 4.7 Article

Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Cardiac & Cardiovascular Systems

Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Emanuele Barbato et al.

Summary: Since the publication of the 2018 ESC/ESH Guidelines, high-quality studies have confirmed the efficacy and safety of RDN in patients with hypertension. The consensus document recommends RDN as an adjunct treatment for uncontrolled resistant hypertension and for patients who cannot tolerate antihypertensive medications. A shared decision-making process is crucial, taking into account the patient's overall cardiovascular risk and the presence of hypertension-mediated organ damage or complications. Multidisciplinary hypertension teams involving experts and interventionalists are needed to evaluate indications and perform RDN procedures. Future research should focus on clinical outcomes and potential indications beyond hypertension.

EUROPEAN HEART JOURNAL (2023)

Add to Collection

Article Medicine, General & Internal

Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial

Michel Azizi et al.

Summary: Two studies showed that ultrasound renal denervation can reduce blood pressure in patients with mild to moderate hypertension and treatment-resistant hypertension. This study aimed to investigate the efficacy and safety of ultrasound renal denervation without the influence of antihypertensive medications. The results of a randomized clinical trial demonstrated that ultrasound renal denervation can significantly reduce daytime ambulatory systolic blood pressure in hypertensive patients at 2 months.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Add to Collection

Article Medicine, General & Internal

Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients

Natalie Staplin et al.

Summary: This study aimed to examine the associations of clinic and 24-h ambulatory blood pressure with all-cause and cardiovascular mortality. The results showed that ambulatory blood pressure, especially night-time blood pressure, was more informative about the risk of all-cause death and cardiovascular death than clinic blood pressure. This study has important implications for the assessment of health outcomes in patients with hypertension.

LANCET (2023)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic

Luke J. Laffin et al.

CIRCULATION (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials

Dexter Canoy et al.

Summary: This study conducted a meta-analysis of individual patient-level data from randomized clinical trials to investigate the long-term effects of antihypertensive drugs on blood pressure. The results showed that antihypertensive drugs were effective in lowering blood pressure, with maximal effect observed after 12 months and gradual attenuation over time. The findings suggest the need for appropriate treatment strategies to sustain long-term blood pressure reductions.

HEART (2022)

Add to Collection

Article Peripheral Vascular Disease

Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial

Kazuomi Kario et al.

Summary: This study found no significant difference in ambulatory blood pressure reductions between renal denervation and a sham procedure in treated patients with resistant hypertension. Although the blood pressure reduction after renal denervation was similar to other sham-controlled studies, the unexpected greater reduction in the sham control group in this study highlights design issues that will be addressed in a new trial.

HYPERTENSION RESEARCH (2022)

Add to Collection

Article Medicine, General & Internal

Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial

Felix Mahfoud et al.

Summary: In this study, the long-term safety and efficacy of renal denervation were evaluated. The results showed that renal denervation produced a clinically meaningful and lasting blood pressure reduction up to 36 months, independent of concomitant antihypertensive medications and without major safety events.

LANCET (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial

Michel Azizi et al.

Summary: This study aims to evaluate the long-term effects and safety of ultrasound RDN for patients with resistant hypertension. The results show that after 2 months of treatment, both the uRDN group and the sham group had similar antihypertensive effects, but the uRDN group required fewer additional medications.

JAMA CARDIOLOGY (2022)

Add to Collection

Article Environmental Sciences

The Impact of the COVID-19 Pandemic on Healthy Lifestyle Behaviors and Perceived Mental and Physical Health of People Living with Non-Communicable Diseases: An International Cross-Sectional Survey

Salma Azzouzi et al.

Summary: The COVID-19 pandemic has significantly impacted the healthy lifestyle behaviors and perceived health among adults with non-communicable diseases (NCDs). This study found that individuals with NCDs experienced worsened physical health and weight gain during the pandemic. However, there was no significant worsening of mental health. These findings highlight the importance of prioritizing the well-being of individuals with NCDs during public health emergencies.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Add to Collection

Article Medicine, General & Internal

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

Deepak L. Bhatt et al.

Summary: The 36-month follow-up of the SYMPLICITY HTN-3 trial demonstrates the long-term safety and efficacy of renal artery denervation in patients with treatment-resistant hypertension. Patients who received renal artery denervation showed significant reductions in blood pressure and better blood pressure control compared to those who received sham control.

LANCET (2022)

Add to Collection

Review Peripheral Vascular Disease

Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic

Reinhold Kreutz et al.

Summary: The COVID-19 pandemic has had a significant impact on various aspects of daily life, including blood pressure control and cardiovascular risk. Lifestyle factors, dietary patterns, alcohol consumption, and other behaviors may influence blood pressure during the pandemic, necessitating preventive measures to improve blood pressure control.

JOURNAL OF HYPERTENSION (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Device Therapy of Hypertension

Felix Mahfoud et al.

Summary: Efforts to improve blood pressure control have shifted towards interventional therapies targeting the sympathetic nervous system, with renal denervation being the most mature technology. Other emerging technologies like baroreflex activation therapy require more human data support. Central nervous system control of circulation remains poorly understood yet vital component, with deep brain stimulation of key cardiovascular control territories showing promise for blood pressure control. Technology targeting hemodynamics of circulation may also be worth exploring for patients with less relevant sympathetic drive to hypertension perpetuation.

CIRCULATION RESEARCH (2021)

Add to Collection

Article Medicine, General & Internal

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

Michel Azizi et al.

Summary: Renal denervation through ultrasound treatment shows promising results in reducing blood pressure for patients with resistant hypertension, with greater effectiveness compared to a sham procedure within 2 months and similar safety outcomes. This may provide an alternative approach for patients with resistant hypertension to avoid adding more antihypertensive medications.

LANCET (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure. An individual participant-level data meta-analysis

Denis Pouchain

EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prioritised endpoints for device-based hypertension trials: the win ratio methodology

David E. Kandzari et al.

Summary: By analyzing the data from the SPYRAL HTN-ON MED pilot study, a win ratio analysis was conducted to determine the effectiveness of RDN treatment in hypertensive patients. Using a prioritised hierarchical endpoint with 24-hour mean ambulatory blood pressure, office blood pressure, and medication burden, RDN was found to be the winner in a significantly higher number of pairs compared to the loser, with a win ratio of 2.78 and a net benefit statistic of 0.42.

EUROINTERVENTION (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design

Michael Boehm et al.

CLINICAL RESEARCH IN CARDIOLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies

Felix Mahfoud et al.

EUROPEAN HEART JOURNAL (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation

Raymond R. Townsend et al.

EUROINTERVENTION (2020)

Add to Collection

Article Medicine, General & Internal

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

Michael Bohm et al.

LANCET (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Device-based therapies for arterial hypertension

Lucas Lauder et al.

NATURE REVIEWS CARDIOLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Renal Denervation in High-Risk Patients With Hypertension

Felix Mahfoud et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies

Felix Mahfoud et al.

EUROPEAN HEART JOURNAL (2020)

Add to Collection

Article Medicine, General & Internal

Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes

Wen-Yi Yang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Add to Collection

Article Medicine, General & Internal

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

David E. Kandzari et al.

LANCET (2018)

Add to Collection

Article Medicine, General & Internal

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

Michel Azizi et al.

LANCET (2018)

Add to Collection

Article Medicine, General & Internal

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

Raymond R. Townsend et al.

LANCET (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

Drug-eluting stents versus bare metal stents for the prevention of restenosis in patients with renovascular disease

Christian Bradaric et al.

EUROINTERVENTION (2017)

Add to Collection

Review Medicine, General & Internal

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

Dena Ettehad et al.

LANCET (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis

Sebastian Ewen et al.

CLINICAL RESEARCH IN CARDIOLOGY (2015)

Add to Collection

Review Peripheral Vascular Disease

Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials

Costas Thomopoulos et al.

JOURNAL OF HYPERTENSION (2014)

Add to Collection

Article Medicine, General & Internal

Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis

Christopher J. Cooper et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Add to Collection

Article Cardiac & Cardiovascular Systems

Nine-Month Results of the REFORM Study: A Prospective, Single-Arm, Multicenter Clinical Study of the Safety and Effectiveness of the Formula™ Balloon-Expandable Stent for Treatment of Renal Artery Stenosis

Robert M. Bersin et al.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2013)

Add to Collection

Article Cardiac & Cardiovascular Systems

Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: Results from the HERCULES trial

Michael R. Jaff et al.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2012)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Safety and Efficacy of Renal Artery Stenting Following Suboptimal Renal Angioplasty for De Novo and Restenotic Ostial Lesions: Results from a Nonrandomized, Prospective Multicenter Registry

John R. Laird et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2010)

Add to Collection

Article Medicine, General & Internal

Stent Placement in Patients With Atherosclerotic Renal Artery Stenosis and Impaired Renal Function A Randomized Trial

Liesbeth Bax et al.

ANNALS OF INTERNAL MEDICINE (2009)

Add to Collection

Article Cardiac & Cardiovascular Systems

Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty - The ASPIRE-2 study

K Rocha-Singh et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)

Add to Collection

Article Peripheral Vascular Disease

Superiority of ambulatory over clinic blood pressure measurement in predicting mortality - The Dublin Outcome Study

E Dolan et al.

HYPERTENSION (2005)

Add to Collection

Article Medicine, General & Internal

The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis

BC van Jaarsveld et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.